Expansion Opportunity OSSIO is rapidly expanding its U.S. footprint, including a new 30,000 sq ft manufacturing and training facility in Palmetto, FL, with plans to hire around 100 employees. This signals growing capacity and a broader service area ideal for regional distributors, hospital networks, and pediatric centers seeking metal-free fixation solutions.

Pediatric Focus The company recently secured an exclusive distribution agreement with OrthoPediatrics to supply bio-integrative, metal-free fixation technology to U.S. children’s hospitals. This presents a clear entry point for pediatric orthopedic departments and surgeons specializing in fractures and deformities.

Sports Medicine Entry OSSIO launched the OSSIOfiber interference screw for ACL reconstruction, targeting the sports medicine market. This creates a growth channel with orthopedics groups and ASCs performing ACL and soft-tissue fixation procedures seeking bio-integrative, metal-free solutions.

Bio-Integrative Advantage The OSSIOfiber platform emphasizes bone regeneration with no permanent left behind, appealing to surgeons valuing biologically friendly implants and potential payor appeal for reduced long-term complication costs, suggesting messaging and case studies focused on outcomes and cost-of-care savings.

Scale and Financing With a recent $50M financing facility and headcount expansion, OSSIO is positioned for accelerated commercialization and manufacturing scale. This creates opportunities for enterprise accounts, long-term procurement contracts, and partnerships with hospital systems seeking innovative fixation options.